A randomized, double-blind, positive-controlled, Phase-II clinical trial to evaluate efficacy and safety of Fuke Qianjin capsule in Pakistani patients with pelvic inflammatory disease
Article in Frontiers in Pharmacology (March 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (March 2024)
Article in Drug Discoveries & Therapeutics (February 2024)
Article in Heliyon (December 2023)